Importantly, this trial primarily enrolled people without type 2 diabetes
Glucagon-like peptide-1 receptor (GLP-1R) is a member of the glucagon-like receptor subfamily of the G protein-coupled receptor B family and is widely expressed in the cardiovascular system, brain, hypothalamus, hippocampus, kidney, liver, lung, digestive tract, pancreas, fat and skeletal muscle ( Due to the wide distribution of GLP-1R, the pharmacological effects of GLP-1RA after interaction with receptors are also extremely extensive
Retatrutide, also known by its development code LY3437943, is a 39-amino-acid synthetic peptide engineered by Eli Lilly
Mild fatigue, headaches, and injection-site reactions can also occur but are usually short-lived